lobbying_activities: 2593362

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2593362	16fbec92-4dbc-4f83-8385-f26caebfcd6b	1A	WELSH ROSE, LLC	401104285	ALNYLAM PHARMACEUTICALS, INC.	2021	first_quarter	MMM	PL 117-2, The American Rescue Plan Act of 2021; REFUND Act; home infusion issues and April 2021 Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).	HOUSE OF REPRESENTATIVES	40000		0	0	2021-04-12T12:24:54.327000-04:00